Moving Immunotherapy into the neo-adjuvant/adjuvant setting

preview_player
Показать описание

  1. Axiom Healthcare Strategies
Рекомендации по теме
Moving Immunotherapy into 0:56:43

Moving Immunotherapy into the neo-adjuvant/adjuvant setting

Leveraging Neoadjuvant and 1:29:06

Leveraging Neoadjuvant and Adjuvant Immunotherapy to Improve Outcomes in Early-Stage Cancers

Adjuvant and neoadjuvant 0:02:59

Adjuvant and neoadjuvant immunotherapy in MCC

Neoadjuvant and adjuvant 0:03:02

Neoadjuvant and adjuvant immunotherapy in non-small cell lung cancer

Moving immunotherapy and 0:03:25

Moving immunotherapy and targeted therapies to the frontline setting

Ahmed Kaseb, MD, 0:02:27

Ahmed Kaseb, MD, explains the role of immunotherapy in neo-adjuvant treatment of resectable HCC

Controversy Debate 1: 0:11:12

Controversy Debate 1: Is it justified to move from adjuvant to neo-adjuvant treatment? - No

Neoadjuvant vs. Adjuvant 0:22:25

Neoadjuvant vs. Adjuvant vs. None – “Perioperative Therapy”

NeoAdjuvant and Adjuvant 0:24:54

NeoAdjuvant and Adjuvant Therapy, A Revolution in Melanoma

Moving immunotherapy to 0:02:22

Moving immunotherapy to earlier lines in NSCLC

Neoadjuvant and Adjuvant 0:20:29

Neoadjuvant and Adjuvant Chemotherapy in Bladder Cancer

Daneng Li, MD, 0:03:20

Daneng Li, MD, regarding the role of immunotherapy in the neoadjuvant and adjuvant setting for HCC

NeoAdjuvant & Adjuvant 0:25:55

NeoAdjuvant & Adjuvant Therapy: Questions Getting Answered

Resectable Melanoma: Perspectives 1:09:01

Resectable Melanoma: Perspectives on Using Immune-Based Adjuvant and Neoadjuvant Therapy

Adjuvant atezolizumab in 0:01:41

Adjuvant atezolizumab in NSCLC

Resectable Melanoma: Immune 1:02:49

Resectable Melanoma: Immune Checkpoint Inhibitors as Adjuvant and Neoadjuvant Therapy

Adjuvant-Neoadjuvant treatment | 0:22:06

Adjuvant-Neoadjuvant treatment | Lung Cancer | Latest Innovation | Immunotherapy | Targeted therapy

Neo-Adjuvant and Adjuvant 0:21:30

Neo-Adjuvant and Adjuvant Therapy, A Revolution in Melanoma

ESMO 2020 Highlights 0:02:12

ESMO 2020 Highlights on adjuvant osimertinib for EGFR mutated NSCLC: The ADAURA study

Neoadjuvant and Adjuvant 0:08:00

Neoadjuvant and Adjuvant Therapy in Muscle-Invasive Bladder Cancer

Lung Cancer Webinar 0:58:40

Lung Cancer Webinar on Neo-Adjuvant and Adjuvant Therapy

Adjuvant Therapy in 0:01:43

Adjuvant Therapy in Melanoma: What’s Coming Next?

Linking Immunotherapy to 0:54:59

Linking Immunotherapy to Better Outcomes in Resectable Melanoma

Marking New Milestones 0:59:24

Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer